Loading…
SkinHealth Systems Inc. is projected to decline to $0.9117 by 2027, a -3% move from its current price of $0.9431. SKIN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.8912 | $0.9421 | $0.996 | -0.11% |
| Jul 14 | $0.8699 | $0.9411 | $1.02 | -0.21% |
| Jul 15 | $0.8538 | $0.9401 | $1.04 | -0.32% |
| Jul 16 | $0.8403 | $0.9391 | $1.05 | -0.42% |
| Jul 17 | $0.8285 | $0.9381 | $1.06 | -0.53% |
| Jul 18 | $0.8178 | $0.9371 | $1.07 | -0.63% |
| Jul 19 | $0.8081 | $0.9361 | $1.08 | -0.74% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8081 | $0.9361 | $1.08 | -0.74% |
| Week 2 | $0.7547 | $0.9292 | $1.14 | -1.47% |
| Week 3 | $0.7149 | $0.9224 | $1.19 | -2.20% |
| Week 4 | $0.6822 | $0.9156 | $1.23 | -2.92% |
| Week 5 | $0.6541 | $0.9088 | $1.26 | -3.64% |
| Week 6 | $0.6292 | $0.9021 | $1.29 | -4.35% |
| Week 7 | $0.6068 | $0.8954 | $1.32 | -5.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SkinHealth Systems Inc. is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions across the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. Its offerings include HydraFacial, a treatment that cleanses, extracts, and hydrates the skin with proprietary solutions and serums, and Syndeo devices designed to connect providers to consumer preferences for a personalized experience.
The company also supplies consumables such as single-use tips, solutions, and serums used in HydraFacial treatments, along with SkinStylus SteriLock Microsystem for microneedling and nanoneedling, and Keravive peptide solutions and take-home sprays for scalp health. Its MyBeautyHealth mobile application supports loyalty, savings, skin concerns tracking, personalized treatment plans, and locating Hydrafacial providers. SkinHealth Systems Inc.
was formerly The Beauty Health Company and changed its name in April 2026; it was founded in 1997 and is headquartered in Long Beach, California.
SkinHealth Systems Inc. trades under the symbol SKIN and has a current price of $0.9431 with a market capitalization of $122.23M, ranking 4124 among peers.
The 2026 forecast places the average price at $0.9431, with a low of $0.58 and a high of $1.18, for a 0% ROI and a Neutral sentiment. The forecast shows bullish momentum building in later years, with the 2030 average price projected at $1.53 and a max of $2.65 (ROI 62.1%), suggesting meaningful upside from current levels.
Longer-term projections extend into 2040 and 2050, with the 2040 average at $1.97 and a max of $4.32 (ROI 108.7%), and the 2050 average at $4.29 with a max of $9.87 (ROI 355%), both labeled bullish. These figures imply a multi-year upward trajectory despite near-term variability.
A major floor 60.3% below — a decisive break under it would weaken the trend.
The nearest floor, 35.5% below — buyers have tended to step in here.
The nearest ceiling, 17.7% above — a clean break opens room to run.
A major ceiling 46.1% above — clearing it would confirm fresh momentum.
Key SKIN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SKIN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.9536 | Sell | $0.9205 | Buy |
| MA 10 | $0.8278 | Buy | $0.8581 | Buy |
| MA 20 | $0.7417 | Buy | $0.7907 | Buy |
| MA 50 | $0.73 | Buy | $0.7805 | Buy |
| MA 100 | $0.8605 | Buy | $0.8922 | Buy |
| MA 200 | $1.17 | Sell | $1.11 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.36 | Neutral |
| Stoch RSI (14) | 46.21 | Neutral |
| CCI (20) | 105.90 | Buy |
| Williams %R (14) | -42.55 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 36.43 | Buy |
| Bollinger %B (20,2) | 0.80 | Neutral |
| Stochastic %K (14) | 57.45 | Neutral |
| TRIX (15) | 0.54 | Buy |
| Awesome (5,34) | 0.23 | Buy |
| Ultimate (7,14,28) | 65.69 | Neutral |
| Momentum (10) | 0.27 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 1.06 | Sell |
| ADX (14) | 19.12 | Neutral |
| ATR (14) | 0.05 | Info |
The near-term technical picture is bullish. The RSI14 sits at 60, supporting constructive momentum, with a price structure hovering around key moving averages.
The 50-day simple moving average is $0.7286 and the 200-day simple moving average is $1.17, indicating the stock is trading near mid-range between short- and longer-term averages. Support is indicated at $0.608 and resistance at $1.11, framing a modest upside path if price can push through the resistance level.
Over the last 30 days, the price ranged from $0.6481 to $1.37, underscoring the near-term volatility within the established support and resistance levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.58 | $0.9431 | $1.18 | 0% | Neutral | |
| $0.6614 | $0.9117 | $1.36 | -3% | Neutral | |
| $0.585 | $0.8569 | $1.36 | -9% | Neutral | |
| $0.6209 | $0.9582 | $1.60 | +2% | Neutral | |
| $0.9077 | $1.47 | $2.55 | +56% | Bullish | |
| $0.8612 | $1.46 | $2.62 | +54% | Bullish | |
| $0.7405 | $1.31 | $2.42 | +38% | Bullish | |
| $0.7422 | $1.36 | $2.60 | +45% | Bullish | |
| $0.6847 | $1.31 | $2.55 | +39% | Bullish | |
| $0.7928 | $1.57 | $3.14 | +67% | Bullish | |
| $0.8385 | $1.86 | $4.09 | +98% | Bullish | |
| $1.81 | $4.03 | $9.26 | +327% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.58 | $0.9431 | $1.16 | +0.00% |
| August 2026 | $0.7299 | $0.8845 | $1.12 | -6.21% |
| September 2026 | $0.6968 | $0.8563 | $1.10 | -3.18% |
| October 2026 | $0.7316 | $0.9101 | $1.19 | +6.28% |
| November 2026 | $0.7348 | $0.9235 | $1.23 | +1.48% |
| December 2026 | $0.6903 | $0.8761 | $1.18 | -5.14% |
Click any year to see its month-by-month SKIN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The SKIN price prediction for 2026 points to an average of $0.9431 (low $0.58, high $1.18) — a potential gain of 0% on today's $0.9431. Price action looks broadly range-bound.
In 2027, SKIN is projected to trade between $0.6614 and $1.36, averaging $0.9117 — a potential decline of -3% from today's $0.9431. That is -3% versus the projected 2026 average. A consolidation phase looks the most probable path here.
SkinHealth Systems Inc.'s 2028 outlook centres on $0.8569, within a $0.585 to $1.36 range. That is -6% versus the projected 2027 average. That marks a -9% change versus current levels. Price action looks broadly range-bound.
By 2029, SKIN could reach as high as $1.60, with a base case around $0.9582 and support toward $0.6209 — roughly +2% from $0.9431. A consolidation phase looks the most probable path here.
Expect SKIN to range from $0.9077 to $2.55 through 2030. The $1.47 average target implies a +56% move from current prices. That is up +53% on the projected 2029 average. Momentum favours further upside here.
The SKIN price prediction for 2031 points to an average of $1.46 (low $0.8612, high $2.62) — a potential gain of +54% on today's $0.9431. Buyers look set to stay in control over this stretch.
In 2032, SKIN is projected to trade between $0.7405 and $2.42, averaging $1.31 — a potential gain of +38% from today's $0.9431. That is -10% versus the projected 2031 average. Momentum favours further upside here.
SkinHealth Systems Inc.'s 2033 outlook centres on $1.36, within a $0.7422 to $2.60 range. That is up +4% on the projected 2032 average. That marks a +45% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, SKIN could reach as high as $2.55, with a base case around $1.31 and support toward $0.6847 — roughly +39% from $0.9431. Momentum favours further upside here.
Expect SKIN to range from $0.7928 to $3.14 through 2035. The $1.57 average target implies a +67% move from current prices. That is up +20% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The SKIN price prediction for 2040 points to an average of $1.86 (low $0.8385, high $4.09) — a potential gain of +98% on today's $0.9431. Momentum favours further upside here.
In 2050, SKIN is projected to trade between $1.81 and $9.26, averaging $4.03 — a potential gain of +327% from today's $0.9431. That is up +116% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in SKIN today (≈ 1,060.332945 SKIN) could be worth
$4,268.1
+$3,268.1 (+327%) by 2050 · US Dollar
Based on the average projected SKIN price of $4.03 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SKINwould be worth at today's price.
$1,000 invested in SKIN on Jul 10, 2025 (≈ 490.196088 SKIN) would be worth
$462.3
-$537.7 (-53.8%) today · 0.46× · US Dollar
Based on a SKIN entry price of $2.04 vs. today's $0.9431.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.726 | $1,299.04 | +29.9% |
| 1 month ago | $0.665 | $1,418.2 | +41.8% |
| 3 months ago | $0.898 | $1,050.22 | +5.0% |
| 6 months ago | $1.51 | $624.57 | -37.5% |
| 1 year ago | $2.04 | $462.3 | -53.8% |
| All time (5.0y) ago | $19.05 | $49.51 | -95.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SKIN forecast.
Our base-case forecast reaches $1.90 around 2050.
Implied market cap at $1.90: $246.24M
Looking further ahead, the multi-year forecast shows a bullish trajectory starting in 2030, with an average price of $1.53 and a max of $2.65 (ROI 62.1%). The 2031 forecast also remains bullish with an average of $1.51 and ROI of 59.6%, followed by continued upside in 2032–2035 as averages exceed $1.35–$1.67 and ROIs range from roughly 42.9% to 77.2%.
By 2040, the average price is projected at $1.97 with a max of $4.32 (ROI 108.7%), and by 2050 the average rises to $4.29 with a max of $9.87 (ROI 355%), all carrying bullish sentiment. These are estimates of price paths and potential returns, not guarantees, and reflect modeled projections with inherent uncertainty and market risk.
Tap a question to reveal the answer.
The current price is $0.9431 and the market cap is $122.23M. The ranking shown is 4124.
For 2030, the forecast shows an average price of $1.53, a min of $0.9449, a max of $2.65, with a ROI of 62.1% and a bullish sentiment.
Yes. The 2050 forecast lists a max of $9.87 with an average of $4.29 and a ROI of 355%, under a bullish sentiment.
The 30-day range is $0.6481 to $1.37. The RSI14 is 60, with a SMA50 of $0.7286 and a SMA200 of $1.17. Support is at $0.608 and resistance at $1.11.
SkinHealth Systems Inc. is a global medical aesthetics company offering an integrated ecosystem including HydraFacial, Syndeo devices, consumables, SkinStylus SteriLock Microsystem, Keravive peptide solutions, take-home sprays, and the MyBeautyHealth app for loyalty and treatment planning.
SkinHealth Systems Inc. Community Discussion
0Share your SkinHealth Systems Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.